Af disse patienter havde mange andre sygdomme eller fik samtidigt anden medicin, der kunne have forårsaget eller medvirket til disse hændelser.
Fatal and non-fatal intracranial haemorrhage (ICH) have been reported in patients receiving APTIVUS, many of whom had other medical conditions or were receiving concomitant medicinal products that may have caused or contributed to these events.